Skip to contentB
biote Corp.
B
BTMDbiote Corp. Q3 2024 · 10-Q
Revenue$51.38M$51.38M+12.8% vs Q3 2023 Net Income$10.70M$10.70M+42.1% vs Q3 2023 EPS Diluted$0.33$0.33+37.5% vs Q3 2023 Operating Income$12,184,000+60.3% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
biote Corp. · CIK 1819253 · Engraved from SEC EDGAR
derived
Free Cash Flowderived$14,006,000N/M Margins · derivedOperating margin23.7%+7.0 pt vs Q3 2023
Net margin20.8%+4.3 pt vs Q3 2023
ended Sep 30, 2024 · filed Nov 12, 2024 · 43 d after period end